Streptomycin is an aminoglycoside antibiotic injection. The Renata PLC. brand comes as a 1 gm/vial powder for injection, used for certain bacterial infections as decided by a doctor.
There are 3 brands of Streptomycin listed in Bangladesh. 2 of them have a lower unit price than Streptomycin.
What is Streptomycin 1 gm/vial Injection?
Streptomycin is an antibiotic belonging to the aminoglycoside group. The Renata PLC. product is a 1 gm/vial injection, a powder that is made into a solution before use. It is used for some moderate to severe bacterial infections, including certain cases of tuberculosis, when a doctor decides it is appropriate. Because it is an injection, it is given by a healthcare professional. The dose and course are set by the doctor based on the infection and the patient's condition. It is not a medicine for self-treatment.
Uses of Streptomycin
Streptomycin is used to treat certain moderate to severe infections caused by bacteria that are sensitive to it. These include some cases of tuberculosis and other specific infections as determined by a doctor. It is not for viral infections such as colds or flu. Only a doctor can confirm whether this antibiotic is suitable for a particular infection.
How to use Streptomycin
Streptomycin 1 gm/vial is an injection, so it is prepared and given by a healthcare professional, usually in a hospital or clinic. The doctor decides the dose, how often it is given and how long the course lasts. Do not attempt to use it yourself. Follow the doctor's instructions and keep all appointments for monitoring during treatment.
Side effects of Streptomycin
Like all medicines, streptomycin can cause side effects. Reported reactions include effects on the nerves and hearing or balance, skin rash, fever, blood changes and muscle weakness. Some effects can be serious. Tell your doctor promptly if you notice hearing changes, dizziness, numbness, rash or any unusual symptoms during or after treatment.
Safety and precautions
Before using streptomycin, tell your doctor if you have myasthenia gravis or other neuromuscular disorders, kidney problems, hearing loss or vertigo. It should be used with caution in elderly people and children, and in pregnancy and breastfeeding. Streptomycin can harm an unborn baby, so tell your doctor if you are pregnant or planning pregnancy. Your doctor will decide if it is suitable for you.
Frequently asked questions
What does 1 gm/vial mean for this injection?
It means each vial contains streptomycin powder that, when prepared, provides 1 gram of the medicine. The vial is a single-use container. A healthcare professional prepares and gives the injection; the doctor decides how much is used.
What is Streptomycin used for and what kind of medicine is it?
Streptomycin is an aminoglycoside antibiotic. It is used for certain moderate to severe bacterial infections, including some cases of tuberculosis, when a doctor decides it is appropriate. It does not treat viral infections.
How should Streptomycin injection be taken?
It is given by a healthcare professional as an injection, usually in a hospital or clinic. The doctor decides the dose, how often it is given and the length of the course. Never use it on your own; follow your doctor's instructions and attend monitoring appointments.
Who should ask a doctor before using Streptomycin?
Anyone with kidney problems, hearing loss, vertigo, myasthenia gravis or other neuromuscular disorders should tell their doctor first. Pregnant or breastfeeding women, elderly people and children also need a doctor's advice. Always discuss your full medical history before treatment.
Streptomycin is indicated for the treatment of individuals with moderate to severe infections caused by susceptible strains of microorganisms in the specific conditions listed below:
Mycobacterium tuberculosis: The Advisory Council for the Elimination of Tuberculosis, the American Thoracic ... Read moreStreptomycin is indicated for the treatment of individuals with moderate to severe infections caused by susceptible strains of microorganisms in the specific conditions listed below:
Mycobacterium tuberculosis: The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Center for Disease Control recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH or rifampin resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. In the past when the national rate of primary drug resistance to isoniazid was known to be less than 4% and was either stable or declining, therapy with two and three drug regimens was considered adequate. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered. Streptomycin is also indicated for therapy of tuberculosis when one or more of the above drugs is contraindicated because of toxicity or intolerance. The management of tuberculosis has become more complex as a consequence of increasing rates of drug resistance and concomitant HIV infection. Additional consultation from experts in the treatment of tuberculosis may be desirable in those settings.
Non-tuberculosis infections: The use of streptomycin should be limited to the treatment of infections caused by bacteria which have been shown to be susceptible to the antibacterial effects of streptomycin and which are not amenable to therapy with less potentially toxic agents.
H. influenzae (in respiratory, endocardial, and meningeal infections - concomitantly with another antibacterial agent)
K. pneumoniae pneumonia (concomitantly with another antibacterial agent)
E.coli, Proteus, A. aerogenes, K. pneumoniae, and Enterococcus faecalis in urinary tract infections
Streptococcus viridans, Enterococcus faecalis (in endocardial infections - concomitantly with penicillin)
Gram-negative bacillary bacteremia (concomitantly with another antibacterial agent)
To reduce the development of drug-resistant bacteria and maintain the effectiveness of streptomycin and other antibacterial drugs, streptomycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy
Pharmacology
Aminoglycosides like Streptomycin "irreversibly" bind to specific 30S-subunit proteins and 16S rRNA. Specifically Streptomycin binds to four nucleotides of 16S rRNA and a single amino acid of protein S12. This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S subunit. This region interacts with the wobble base in the anticodon of tRNA. This leads to interference with the initiation complex, misreading of mRNA so incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into nonfunctional monosomes.
Dosage & Administration
Tularaemia:
Adult: 1-2 g daily in divided doses for 7-14 days until the patient is afebrile for 5-7 days.
Child: 15 mg/kg bid for at least 10-14 days. Max: 2 g daily
Bacterial endocarditis:
Adult: Streptococcal endocarditis: 1 g bid for 1 wk, then 500 mg bid for the 2nd wk. Enterococcal endocarditis: 1 g bid for 2 wk then 500 mg bid for an additional 4 wk. Doses are given in combination with penicillin.
Child: Enterococcal endocarditis: 20-30 mg/kg daily in 2 divided doses, in combination w/ penicillin.
Elderly: Streptococcal endocarditis: >60 yr 500 mg bid for the entire 2 wk period.
Tuberculosis:
Adult: 15 mg/kg as a single dose daily. Max: 1 g daily. As part of intermittent regimen: 25-30 mg/kg 2-3 times wkly. Max: 1.5 g/dose.
Child: 20-40 mg/kg as a single dose daily. Max: 1 g daily. As part of intermittent regimen: 25-30 mg/kg 2-3 times wkly. Max: 1.5 g/dose.
Elderly: >40 yr Max: 500-750 mg daily.
Plague:
Adult: 2 g daily in 2 divided doses for a minimum of 10 days.
Child: 30 mg/kg daily in 2-3 divided doses. Max: 2 g daily.
Adult: For concomitant use with other agents and as 2nd line agent: 1-2 g daily in divided doses 6-12 hrly. Max: 2 g daily.
Child: 20-40 mg/kg daily in divided doses 6-12 hrly.
Interaction
Additive neurotoxic and nephrotoxic effect with neomycin, kanamycin, gentamicin, cefaloridine, paronomycin, viomycin, polymyxin B, colistin, tobramycin, and ciclosporin. Enhanced ototoxic and nephrotoxic effect with ethacrynic acid, mannitol, furosemide and possibly other diuretics. May enhance the resp depressant effect of neuromuscular blockers. Increased risk of nephrotoxicity with cephalosporins. Reduced excretion with NSAIDs.
Contraindications
Hypersensitivity to streptomycin and other aminoglycosides.
Streptomycin can cause fetal harm when administered to a pregnant woman. Because streptomycin readily crosses the placental barrier, caution in use of the drug is important to prevent ototoxicity in the fetus. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.
Precautions & Warnings
Patient with neuromuscular disorders (e.g. myasthenia gravis), pre-existing vertigo, or hearing loss. Renal impairment. Elderly, childn. Pregnancy and lactation.
Storage Conditions
Store between 15-30°C. Protect from light.
Alternative brands of Streptomycin
Other brands with the same generic name, cheapest first.